It was once believed that mice had relatively poor vision. Turns out mice are far from blind – and studying how their vision ...

A new study identifies molecular factors that promote small vessel disease—and an active drug that can restore impaired ...

Ellerie was just eight when her parents noticed something was different about the way she was walking, within months she had been diagnosed with brain cancer ...

In a study published in Frontiers in Science, scientists from Purdue University and the Georgia Institute of Technology ...

The students were able to uncover a molecular structural discrepancy more than a decade ago, clearing a path for development ...

In 2025, UC Davis once again proved why it stands among the world’s leading research universities — not only by pushing ...

A new study identifies molecular factors that promote small vessel disease - and an active drug that can restore impaired ...

Cancer is one of the leading causes of death in the U.S., second only to heart disease. But a new cancer treatment method ...

These deals radically reshaped the biopharma world, either by one vaccine rival absorbing another, a Big Pharma doubling down ...

Kyverna Therapeutics stock upgraded to Strong Buy after positive phase 2 results for miv-cel in SPS and MG. Read the latest ...

Drug developers increasingly are harnessing AI to optimise clinical trial patient selection and to interpret results to ...

The Sully family is back and they’re just doing all the stuff they did last time, but slightly different and not as good.